Health Care Provider Resources
Essential Tremor
-
Inclusion
- Over 18 years
- Resident of Alberta, valid PHN (residents of other Canadian provinces will be considered for MRgFUS on a case-by-case basis)
- Willing to attend all study visits
- Diagnosis of ET (PD resting tremor and dystonia tremor may be considered)
- Tremor refractory to adequate trials of at least 2-3 medications or side effects on medications
- Able to communicate sensations during the treatment.
- Postural or intention tremor severity score of 2 or higher on the CRST rating scale while stable on medication.
- Significant disability that affects daily activities despite medications
-
Exclusion
- Uncontrolled medical conditions i.e., unstable cardiac history, drug/alcohol dependence
- Unable to perform MRI
- History of intracranial hemorrhage or epilepsy
- Unable to lay flat for 4-6 hours on treatment table
- Cognitive impairment
- Intraoperative/postoperative bleeding risk
- Unable to communicate with doctors or MRgFUS staff during procedure
Please send referral to the Dr Zelma Kiss (Neurosurgery). Fax number is 403-283-2270.
Self referrals will not be accepted.
NOTE: MRgFUS can only be done on one side of the brain. As a result, only 1 side of the hand/arm can be treated.
MRgFUS does not help with voice or head tremor.
Other medications or surgical options will need to be considered for the other hand/arm at a later date.
For assistance in managing your patient in the community, please click here for suspected Essential Tremor.
Focused Ultrasound: https://www.fusfoundation.org/
Movement Disorders: cmdg.org
Essential Tremor: http://essentialtremor.org/
Dystonia: http://www.dystonia-foundation.org/
Clinical Trials: www.clinicaltrials.gov
Functional Movement Disorders: www.neurosymptoms.org
Obsessive Compulsive Disorder (OCD)
-
Inclusion
- 21-65 years old
- DSM-V diagnosis of OCD with a 5-year illness history & min score of 28 on Y-BOCS scale
- Medication-refractoriness including 1) Failed trial of three or more 1st line medications 2) Attempted augmentation, if tolerated, by at least 2 medications known to be first line treatments for OCD 3) An adequate trial of cognitive behavioural therapy
- Able to communicate sensations during the ExAblate MRgFUS treatment
- Stable dose of medications, 6 weeks prior to study entry
-
Exclusion
- Unstable cardiac status
- Severe kidney disease (eGFR<30)
- Abnormal bleeding and/or coagulopathy
- History of stroke or intracranial hemorrhage
- Untreated, uncontrolled sleep apnea
- Unable to tolerate prolonged stationary supine position
- Unable to communicate with the investigator and staff
- Presence of cognitive impairment, psychosis, or brain tumour
- Substance abuse or dependence within the previous six months.
Please call Dr Beverly Adams (Psychiatry) at 403-944-1491.
To be updated.
OCD Clinic: Access Mental Health at 403-943-1500
OCD Workbook Your Guide to Breaking Free from Obsessive-Compulsive Disorder: https://tinyurl.com/cxy86vbc
American Psychiatric Association Help with Obsessive-Compulsive Disorder: https://www.psychiatry.org/patients-families/ocd
National Alliance on Mental Illness: https://www.nami.org/
Anxiety and Depression Association of America: https://adaa.org/
Help Guide: https://www.helpguide.org/
MRgFUS
Focused Ultrasound: https://www.fusfoundation.org/